Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community. The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care. Read More
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSE: DOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
Healthcare professional network Doximity (NYSE:DOCS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 17.1% year on year to $138.3 million. On the other hand, next quarter’s revenue guidance of $139.5 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 39.3% above analysts’ consensus estimates.
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ended March 31, 2025.
Doximity has been treading water for the past six months, holding steady at $58. However, the stock is beating the S&P 500’s 6.2% decline during that period.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits at high returns.
Based on a technical and fundamental analysis of NYSE:DOCS we are exploring the Growth Potential of DOXIMITY INC-CLASS A (NYSE:DOCS) as It Nears a Breakout.
DOXIMITY INC-CLASS A was identified as a growth stock that isn't overvalued. NYSE:DOCS is excelling in various growth indicators while maintaining a solid financial footing.
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at vertical software stocks, starting with Olo (NYSE:OLO).
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Veeva Systems (NYSE:VEEV) and the best and worst performers in the vertical software industry.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the vertical software industry, including nCino (NASDAQ:NCNO) and its peers.
Looking back on vertical software stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Doximity (NYSE:DOCS) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the vertical software industry, including Upstart (NASDAQ:UPST) and its peers.
NYSE:DOCS is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.
